At the news
? BULLISHIMPACT 6/10 COURT-RULING filed Mar 2, 2026 at 19:00 ET
The District Court for the Eastern District of Pennsylvania dismissed with prejudice the antitrust tying lawsuit against CVS Health Corp and its subsidiaries. The court held that the plaintiffs' single-brand tying product market ("CVS Contract Pharmacy Market") was legally insufficient and that they failed to establish personal jurisdiction over CVS Health. This removes a material litigation overhang for CVS, as the case cannot be refiled.
- Court granted CVS's motion to dismiss the amended complaint with prejudice on March 3, 2026.
- Plaintiffs alleged CVS illegally tied Wellpartner TPA services to CVS Contract Pharmacy services under the 340B Drug Pricing Program.
- Court found the single-brand tying product market ("CVS Contract Pharmacy Market") legally insufficient; Covered Entities can contract with unlimited other pharmacies.
- Court also found it lacked personal jurisdiction over CVS Health Corp (parent company) in Pennsylvania.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access